Private company
TYME TECHNOLOGIES, INC.
TYME TECHNOLOGIES, INC. is an American pharmaceutical preparations company based in Wilmington.2
Last updated Oct 20, 2026.
Overview
- IndustryPharmaceutical Preparations2
- HeadquartersWilmington, United States2
- Incorporated inDE4
- Business address1 Pluckemin Way - Suite 103, Bedminster, Nj 079214
- Filer categoryNon-accelerated filer, Smaller reporting company4
- Legal formCorporation2
- LEI549300HF903Y0NJLOG062
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered addressC/O THE CORPORATION TRUST COMPANY, 19801 Wilmington, United States2
- Registered withDivision of Corporations, Department of State, 55915392
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2022
Financial statements
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Research and development | $3.8M5 | $6.1M5 | $8.8M6 | $14.7M7 | $13.0M8 | $16.7M3 | $13.4M3 | |
| Operating expenses | $25.5M3 | |||||||
| Operating income | -$8.6M5 | -$15.2M5 | -$19.4M6 | -$31.8M7 | -$25.8M8 | -$27.2M3 | -$25.5M3 | |
| Interest | $3.5M5 | $7.4K7 | $114.2K8 | $97.1K3 | $70.2K3 | |||
| Income before tax | -$23.6M3 | |||||||
| Income tax | $05 | $05 | $05 | |||||
| Net income | -$11.7M5 | -$15.2M5 | -$19.0M6 | -$33.0M7 | -$22.0M8 | -$29.0M3 | -$23.6M3 |
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Cash | $4.4M5 | $6.1M5 | $10.5M6 | $29.0M6 | $14.3M7 | $26.7M8 | $107.5M3 | $13.7M3 |
| Current assets | $4.5M11 | $6.3M12 | $10.7M5 | $29.7M6 | $16.1M7 | $28.1M8 | $109.7M3 | $78.9M3 |
| Total assets | $4.5M11 | $6.3M12 | $10.7M5 | $31.0M6 | $17.5M7 | $29.5M8 | $110.3M3 | $88.0M3 |
| Current liabilities | $1.5M11 | $1.9M12 | $3.3M5 | $4.5M6 | $6.2M7 | $5.6M8 | $5.6M3 | $7.4M3 |
| Total liabilities | $1.5M11 | $1.9M12 | $3.3M5 | $4.5M6 | $7.8M7 | $10.5M8 | $8.5M3 | $7.9M3 |
| Retained earnings | -$160.4M3 | |||||||
| Shareholders’ equity | $3.0M5 | $4.4M12 | $7.4M6 | $26.5M7 | $9.7M8 | $19.0M3 | $101.8M3 | $80.1M3 |
| Shares outstanding | 86.8M shares11 | 84.1M shares12 | 89.3M shares12 | 101.2M shares5 | 112.0M shares6 | 123.3M shares7 | 172.2M shares8 | 172.2M shares13 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Corporate structure
TYME TECHNOLOGIES, INC. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of TYME TECHNOLOGIES, INC.
- Steve Hoffman Filed SC 13G/A on TYME TECHNOLOGIES, INC., latest Sep 16, 2022 (2 filings since Feb 8, 2022)
- TYME TECHNOLOGIES, INC. Wilmington, Delaware, United States
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What TYME TECHNOLOGIES, INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Operating-lease assets (leased space) | $38.2K3 Mar 31, 2022 | $75.5K3 Mar 31, 2021 | −49.3% |
Investments
Leadership
Who has led TYME TECHNOLOGIES, INC., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
Chief operating officer
- Chief executive officerRichard Anthony Cunningham Nov 30, 2020 to Sep 16, 202214
- PresidentBen R. Taylor Jul 27, 2017 to May 18, 202015
- Chief financial officerFrank L. Porfido Jun 16, 2021 to Sep 16, 202216
- Chief financial officerBen R. Taylor Jul 27, 2017 to May 18, 202015
- Chief operating officerMichele Ilene Korfin Mar 25, 2019 to May 18, 202017
- Chief operating officerMichael Demurjian Jul 27, 2017 to Jun 28, 201818
Board members and other officers (18)
- Acting Chief Medical OfficerTornout Jan M. Van Apr 14, 2021 to Apr 26, 202219
- EVP, Product DevelopmentJohn M. Rothman Aug 24, 2020 to Aug 24, 202020
- OfficerJames Biehl May 7, 2019 to May 18, 202021
- OfficerJonathan Eckard May 29, 2018 to Sep 16, 202222
- Corporate ControllerBarbara Galaini Sep 5, 2018 to Sep 16, 202223
- Chief Medical OfficerPriore Giuseppe Del Jul 27, 2017 to May 18, 202024
- Board memberChristine D. Baker Mar 25, 2022 to Sep 16, 202225
- Board memberRichard Anthony Cunningham Nov 30, 2020 to Nov 30, 202014
- Board memberTommy Thompson Feb 14, 2018 to Aug 27, 201926
- Board memberDonald W. Degolyer May 29, 2018 to Sep 16, 202227
- Board memberDavid Carberry Jul 27, 2017 to Sep 16, 202228
- Board memberGerald H. Sokol Jul 27, 2017 to Sep 16, 202229
- Board memberJames Biehl Jul 27, 2017 to Sep 17, 201830
- Board memberMichael Demurjian Jul 27, 2017 to Jun 28, 201818
- Board memberPaul L. Sturman Jul 27, 2017 to Aug 26, 202131
- Board memberTimothy Tyson Jul 27, 2017 to Sep 16, 202232
- Board memberJonathan Eckard Nov 17, 2017 to Nov 17, 201733
- General counselJames Biehl Sep 17, 2018 to Sep 16, 202234
Former names
- GLOBAL GROUP ENTERPRISES CORP.Feb 2, 2012 to Sep 19, 20144
Timeline
- Sep 16, 20228-K Completed an acquisition or sale; Listing notice or transfer; Change to shareholders' rights35
- Sep 15, 20228-K Shareholder vote; Other events36
- Sep 7, 20228-K Other events37
- Sep 6, 20228-K Executive or director change38
- Sep 2, 20228-K Other events39
- Aug 24, 20228-K Other events40
- Jul 5, 20228-K Entered a material agreement; Other events41
- Jun 23, 20228-K Listing notice or transfer42
- Apr 29, 20228-K Executive or director change; Bylaws or fiscal year changed; Other events43
- Apr 19, 20228-K Entered a material agreement44
- Mar 29, 20228-K Regulation FD disclosure45
- Mar 25, 20228-K Executive or director change46
- Nov 30, 2020New chief executive Richard Anthony Cunningham becomes CEO14
- Aug 22, 2014Founded TYME TECHNOLOGIES, INC. is founded2
Calendar
When it reported results
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
139 filings to the SEC since October 2021: 2 annual reports, 3 quarterly reports, 18 major events, 92 insider forms, 5 large holders, 19 other. The latest 20:
- Sep 30, 202215-12G EDGAR
- Sep 21, 2022EFFECT EDGAR
- Sep 21, 2022EFFECT EDGAR
- Sep 16, 2022S-8 POS S-8 POS (333-227077) EDGAR
- Sep 16, 2022S-8 POS EDGAR
- Sep 16, 2022S-8 POS S-8 POS (333-260912) EDGAR
- Sep 16, 2022S-8 POS EDGAR
- Sep 16, 2022S-8 POS S-8 POS (333-255253) EDGAR
- Sep 16, 2022POS AM EDGAR
- Sep 16, 2022POS AM EDGAR
- Sep 16, 2022SC 13G/A EDGAR
- Sep 16, 2022SC 13D/A EDGAR
- Sep 16, 20228-K EDGAR
- Sep 16, 20224 FORM 4 SUBMISSION EDGAR
- Sep 16, 20224 FORM 4 SUBMISSION EDGAR
- Sep 16, 20224 FORM 4 SUBMISSION EDGAR
- Sep 16, 20224 FORM 4 SUBMISSION EDGAR
- Sep 16, 20224 FORM 4 SUBMISSION EDGAR
- Sep 16, 20224 FORM 4 SUBMISSION EDGAR
- Sep 16, 20224 FORM 4 SUBMISSION EDGAR
The 139 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
92 open-market trades by officers, directors and large owners since October 2021: 6 buys and 86 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 7, 2022 | Demurjian Michael10% owner | Sale | 80,000 | $0.24 | $19.2K | Form 4 |
| Sep 6, 2022 | Demurjian Michael10% owner | Sale | 80,000 | $0.26 | $20.8K | Form 4 |
| Aug 23, 2022 | Demurjian Michael10% owner | Sale | 80,000 | $0.29 | $23.2K | Form 4 |
| Aug 22, 2022 | Demurjian Michael10% owner | Sale | 80,000 | $0.29 | $23.2K | Form 4 |
| Jul 26, 2022 | Demurjian Michael10% owner | Sale | 70,000 | $0.29 | $20.3K | Form 4 |
| Jul 25, 2022 | Demurjian Michael10% owner | Sale | 70,000 | $0.29 | $20.3K | Form 4 |
| Jul 12, 2022 | Demurjian Michael10% owner | Sale | 70,000 | $0.29 | $20.3K | Form 4 |
| Jul 11, 2022 | Demurjian Michael10% owner | Sale | 70,000 | $0.29 | $20.3K | Form 4 |
| Jun 28, 2022 | Demurjian Michael10% owner | Sale | 60,000 | $0.27 | $16.2K | Form 4 |
| Jun 27, 2022 | Demurjian Michael10% owner | Sale | 60,000 | $0.26 | $15.6K | Form 4 |
| Jun 22, 2022 | Hoffman SteveDirector | Sale | 78,125 | $0.27 | $21.1K | Form 4 |
| Jun 21, 2022 | Hoffman SteveDirector | Sale | 78,125 | $0.26 | $20.3K | Form 4 |
| Jun 15, 2022 | Demurjian Michael10% owner | Sale | 60,000 | $0.26 | $15.6K | Form 4 |
| Jun 14, 2022 | Demurjian Michael10% owner | Sale | 60,000 | $0.25 | $15.0K | Form 4 |
| Jun 9, 2022 | Hoffman SteveDirector | Sale | 78,125 | $0.27 | $21.1K | Form 4 |
| Jun 8, 2022 | Hoffman SteveDirector | Sale | 78,125 | $0.27 | $21.1K | Form 4 |
| Jun 1, 2022 | Demurjian Michael10% owner | Sale | 66,903 | $0.25 | $16.7K | Form 4 |
| May 31, 2022 | Demurjian Michael10% owner | Sale | 53,097 | $0.25 | $13.3K | Form 4 |
| May 26, 2022 | Hoffman SteveDirector | Sale | 78,125 | $0.24 | $18.8K | Form 4 |
| May 25, 2022 | Hoffman SteveDirector | Sale | 78,125 | $0.24 | $18.8K | Form 4 |
All 92 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Steve HoffmanSC 13G/A, 2 filings Feb 8, 2022 to Sep 16, 202249
SEC filer profile
How TYME TECHNOLOGIES, INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARTYME TECHNOLOGIES, INC.1
- CIK0001537917
- Employer ID (EIN)45-38645971
- Filer statusNon-accelerated filer<br>smaller reporting company1
- Incorporated inDelaware1
- Fiscal year endsMarch 311
- Industry code (SIC)2834 Pharmaceutical Preparations1
- Business address1 Pluckemin Way - Suite 103, Bedminster, NJ 079211
- Phone212-461-23151
- Shares outstanding172,206,894 as of Aug 4, 202210
- Public float$153.5M as of Sep 30, 202113
- On EDGAR sinceFeb 2, 20121
- Filings618 in all: 4 (325), 8-K (112), 10-Q (33), 3 (21), 10-K (10), NT 10-Q (9), SC 13G/A (8), 424B5 (7)1
All 38 form types
UPLOAD (7), 10-K/A (6), 4/A (6), 425 (6), CORRESP (6), EFFECT (6), S-8 (5), S-8 POS (5), SC 13G (5), 8-K/A (4), DEF 14A (4), S-1/A (4), 424B2 (3), DEFA14A (3), S-3 (3), S-3/A (3), 424B3 (2), POS AM (2), SC 13D (2), 10-QT (1), 15-12G (1), 25-NSE (1), 8-A12B (1), CERTNAS (1), D (1), DEF 14C (1), DEFM14A (1), PRE 14C (1), S-1 (1), SC 13D/A (1)
- Latest filingsAnnual report (10-K) May 25, 2022
Quarterly report (10-Q) Aug 9, 2022
Proxy statement (DEF 14A) Jul 12, 2021
Latest 8-K (8-K) Sep 16, 2022
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15SEC EDGARBen R. Taylor, President
- 16
- 17
- 18
- 19
- 20
- 21SEC EDGARJames Biehl, Officer
- 22SEC EDGARJonathan Eckard, Officer
- 23
- 24
- 25SEC EDGARChristine D. Baker, Board member
- 26SEC EDGARTommy Thompson, Board member
- 27SEC EDGARDonald W. Degolyer, Board member
- 28SEC EDGARDavid Carberry, Board member
- 29SEC EDGARGerald H. Sokol, Board member
- 30SEC EDGARJames Biehl, Board member
- 31SEC EDGARPaul L. Sturman, Board member
- 32SEC EDGARTimothy Tyson, Board member
- 33SEC EDGARJonathan Eckard, Board member
- 34SEC EDGARJames Biehl, General counsel
- 35
- 36SEC EDGARShareholder vote; Other events
- 37SEC EDGAROther events
- 38SEC EDGARExecutive or director change
- 39SEC EDGAROther events
- 40SEC EDGAROther events
- 41
- 42SEC EDGARListing notice or transfer
- 43
- 44SEC EDGAREntered a material agreement
- 45SEC EDGARRegulation FD disclosure
- 46SEC EDGARExecutive or director change
- 47
- 48
- 49